Drug intelligence / Profile preview

Effaclar Duo (+)

Development stage: Phase 1
Lead developer: La Roche-Posay
Modality: Small Molecules
Administration: Topical

Overview

Effaclar Duo (+) is a topical dermatological treatment developed for acne-prone and oily skin, formulated by La Roche-Posay. It is designed to reduce the number and severity of acne blemishes, pimples, blackheads, whiteheads, and post-acne marks. The product features a combination of active ingredients including niacinamide (anti-inflammatory and brightening), zinc PCA (sebum regulation), salicylic acid (exfoliant), capryloyl salicylic acid/LHA (gentle exfoliation and pore unclogging), piroctone olamine (antibacterial action), glycerin (hydration), silica (oil absorption/matte effect) and other emollients. Unlike some regional variants containing benzoyl peroxide[1], the standard international/EU/Asia version does not contain benzoyl peroxide but relies on its blend of anti-inflammatory, keratolytic/exfoliating, sebum-regulating, antibacterial, hydrating and soothing agents to treat existing blemishes while preventing new ones from forming[2][3][6][7][8].

Brand names: Effaclar Duo (+)理肤泉清痘调理精华乳（DUO+）
Other names: La Roche-Posay Effaclar Duo (+)

Beyond the preview

Go deeper on Effaclar Duo (+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Effaclar Duo (+).

Explore the full profile